There were no significant associations observed in the placebo arm, however, in the finasteride arm, several SNPs in APEX1, OGG1, NOS3, LIG3 and XRCC1 were associated with risk of total, low- or high-grade prostate cancer. Here, NOS3 is linked to Familial prostate cancer.